Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: 180 Life Sciences Corp. ATNF

MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at … Continue reading

Posted in 180 Life Sciences Corp. ATNF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at LD Micro Main Event

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will participate … Continue reading

Posted in 180 Life Sciences Corp. ATNF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Ring Nasdaq Opening Bell

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that, in celebration of … Continue reading

Posted in 180 Life Sciences Corp. ATNF | Leave a comment